Literature DB >> 19797275

CDC and FDA response to risk of confusion in dosing Tamiflu oral suspension.

Daniel S Budnitz, Linda L Lewis, Nadine Shehab, Debra Birnkrant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19797275     DOI： 10.1056/NEJMc0909190

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Adherence to label and device recommendations for over-the-counter pediatric liquid medications.

Authors:  Daniel S Budnitz; Maribeth C Lovegrove; Kathleen O Rose
Journal:  Pediatrics       Date:  2014-01-06       Impact factor: 7.124
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.